Cite
HARVARD Citation
Nestrasil, I. et al. (2017). Intrathecal enzyme replacement therapy reverses cognitive decline in mucopolysaccharidosis type I. American journal of medical genetics. 173 (3), pp. 780-783. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Nestrasil, I. et al. (2017). Intrathecal enzyme replacement therapy reverses cognitive decline in mucopolysaccharidosis type I. American journal of medical genetics. 173 (3), pp. 780-783. [Online].